IMA Active strengthens its pharmaceutical processing capabilities through the sign of an agreement with Anish Pharma Equip Pvt. Ltd.

  • Reading time 1 min

IMA Active division continues to expand its presence in advanced pharmaceutical technologies through the agreement with Anish Pharma, reinforcing its capabilities in the rapidly growing oral solid dose market. The transaction is expected to close in early 2027 and represents a strategic step in IMA Active international development, bringing together complementary technological expertise and industrial capabilities to support a broader and more diversified pharmaceutical processing offering. By combining the strengths of both organisations, IMA Active aims to offer a more diversified and flexible portfolio, addressing different production requirements, investment priorities and levels of technological complexity. This approach will allow the Group to serve a wider spectrum of pharmaceutical manufacturers, while maintaining a strong focus on process reliability, product quality and long-term customer support.